2026-525448-14-00招募中4 期
Bioequivalence study 1 to compare pharmacokinetics of Parkinson´s disease drugs in healthy volunteers
适应症
试验速览
- 阶段
- 4 期
- 状态
- 招募中
- 入组人数
- 40
- 试验地点
- 1
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 64 years（18-64 Years）
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
研究者
clinical department
Scientific
Orion Corporation
研究点 (1)
Loading locations...
相似试验
已完成
4 期
Bioequivalence study 2 to compare pharmacokinetics of Parkinson´s disease drugs in healthy volunteersParkinson desease2026-525449-57-00Orion Corporation40
尚未招募
不适用
A Study to Compare Biphasic Insulin Aspart Injection (30/70) with NovoMix ® 30 in healthy adult male subjectsCTRI/2026/02/104468Wockhardt limited18
已完成
1 期
A Study to Compare Blood Levels of Different Dosage Formulations of the Study Medicine That Is a CGRP Receptor Antagonist in Healthy AdultsNCT07261371Pfizer64
招募中
1 期
Bioequivalence Study of GZR18 Injection Before and After CMC ChangeNCT07355738Gan & Lee Pharmaceuticals.138
进行中（未招募）
1 期
A Comparative Study of Pharmacokinetics, Pharmacodynamics, Safety, and Immunogenicity of RPH-035 and Ocrevus® in Patients With Relapsing-remitting or Secondary Progressive Multiple Sclerosis With ExacerbationsMultiple SclerosisNCT07597668R-Pharm180